Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.

about

Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.

Item

http://www.wikidata.org/entity/Q39230132

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Pilot study of human recombina ...... l disease acute pain episodes.

@en

Pilot study of human recombina ...... l disease acute pain episodes.

@nl

type

Item

label

Pilot study of human recombina ...... l disease acute pain episodes.

@en

Pilot study of human recombina ...... l disease acute pain episodes.

@nl

prefLabel

Pilot study of human recombina ...... l disease acute pain episodes.

@en

Pilot study of human recombina ...... l disease acute pain episodes.

@nl

P1476

Pilot study of human recombina ...... l disease acute pain episodes.

@en

P2093

Knox H Todd

http://www.w3.org/2001/XMLSchema#string

Marcelo Sandoval

http://www.w3.org/2001/XMLSchema#string

Patricia Coleman

http://www.w3.org/2001/XMLSchema#string

Rahim Govani

http://www.w3.org/2001/XMLSchema#string

Saima Siddiqui

http://www.w3.org/2001/XMLSchema#string

P2860

The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database

Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.

Emergency department management of acute pain episodes in sickle cell disease.

Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration.

Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.

Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations.

Subcutaneous rehydration: updating a traditional technique.

A randomized clinical trial of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in mild to moderately dehydrated children in the emergency department.

Efficacy of tramadol vs meperidine in vasoocclusive sickle cell crisis.

Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.

P304

10-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/15360288.2012.758683

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23527666

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease